Journal of Virology, January 2001, p. 891-902, Vol. 75, No. 2
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.2.891-902.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Wohl Virion Centre, Department of Immunology and Molecular Pathology, Windeyer Institute, University College London, London W1T 4JF,1 and Cancer Research Campaign Viral Oncology Group, Department of Oncology, Wolfson Institute for Biomedical Research, University College London, London WC1E 6AE,2 United Kingdom
Received 16 August 2000/Accepted 10 October 2000
| |
ABSTRACT |
|---|
|
|
|---|
Kaposi's sarcoma-associated herpesvirus (KSHV; human herpesvirus 8) is associated with three human tumors, Kaposi's sarcoma, primary effusion lymphoma (PEL), and multicentric Castleman's disease. KSHV encodes a number of homologs of cellular proteins involved in the cell cycle, signal transduction, and modulation of the host immune response. Of the virus complement of over 85 open reading frames (ORFs), the expression of only a minority has been characterized individually. We have constructed a nylon membrane-based DNA array which allows the expression of almost every ORF of KSHV to be measured simultaneously. A PEL-derived cell line, BC-3, was used to study the expression of KSHV during latency and after the induction of lytic replication. Cluster analysis, which arranges genes according to their expression profile, revealed a correlation between expression and assigned gene function that is consistent with the known stages of the herpesvirus life cycle. Furthermore, latent and lytic genes thought to be functionally related cluster into groups. The correlation between gene expression and function also infers possible roles for KSHV genes yet to be characterized.
| |
INTRODUCTION |
|---|
|
|
|---|
KSHV (Kaposi's sarcoma-associated herpesvirus) is the eighth and most recently identified human herpesvirus (10). Many studies have causally linked KSHV to the pathogenesis of Kaposi's sarcoma (KS) (reviewed in reference 41). KSHV is also specifically associated with primary effusion lymphoma (PEL) (7) and a plasmablastic form of multicentric Castleman's disease (16, 42). KSHV is predicted to encode at least 85 open reading frames (ORFs) which include a number of homologs of cellular genes (30, 35). These cellular homologs may determine the pathogenicity of KSHV (32).
Like all herpesviruses, KSHV establishes a latent infection in cells, persisting as episomal DNA (13). During latency, viral gene expression is restricted to only a few genes (37, 43, 49). These latent genes are thought to maintain the viral episome (3), avoid antiviral host immune responses (15), and provide a growth advantage to infected cells (17, 20, 33). The full repertoire of viral gene expression occurs only during lytic replication, when virus progeny are produced and the host cell is destroyed (34). The study of KSHV has benefited from the establishment of cell lines from PEL (2, 8, 34). These cells harbor the virus in a latent form and can be induced to enter lytic replication by treatment with sodium butyrate or the phorbol ester 12-O-tetradecoylphorbol 13-acetate (TPA) (29, 34).
A number of studies have described KSHV gene expression in latency and during lytic replication (37, 44, 49, 50). KSHV transcripts have been categorized into three classes based on their expression in uninduced and lytically induced PEL (BC-1) cells: class I (constitutive), class II (present in uninduced cells but upregulated with TPA), and class III (only present after induction) (37). However, only one time point after lytic induction was studied, and large probes that were not specific for individual genes were used. The expression pattern of most KSHV genes therefore remains largely unknown.
DNA arrays provide a means to measure the expression of hundreds or thousands of genes simultaneously as well as allowing high-throughput characterization of samples (reviewed in reference 26). Comparison of mRNA populations of cells with a known phenotype under known conditions enables patterns of gene expression to be linked to the status of cell processes and events. The vast amount of data generated with these techniques have dictated the development of mathematical techniques to address the problem of analysis. Clustering algorithms that arrange data based on the coexpression of genes (18) are able to group together genes which have common roles in a cellular process or by the cell type in which they are expressed (1, 12). This method also accurately distinguishes samples from different sources solely by their patterns of gene expression (1). DNA arrays have recently been applied to studies of viral infection, including that of human cytomegalovirus (9, 21, 51). Herpesviruses make ideal candidates for DNA array technology, as every viral gene can be printed onto a single array. Therefore, the complete gene expression profile (transcriptome) of an entire genome can be elucidated from the results of one experiment.
Here, we report on the construction of a DNA array that allows the measurement of the expression level of almost every known KSHV ORF. We studied the expression of the viral genome during latency and during TPA-induced lytic replication in a PEL cell line and used cluster analysis to arrange genes according to their expression profile. This method groups together genes which may be involved in a common process and arranges genes in a temporal order consistent with the known stages of herpesvirus replication. This revealed that K10 has an expression profile similar to that of T0.7 RNA, a known latent transcript. The correlation between gene expression and function also suggests possible roles for genes that have yet to be characterized. We have made an initial demonstration of the feasibility of this approach by the discovery of a novel transcribed ORF (K10.7) with homology to known interferon regulatory factors (IRFs). Reverse transcription (RT)-PCR confirms array data suggesting that KSHV encodes four full-length IRF-related proteins.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Array elements.
Approximately 350 bp of DNA sequence was
amplified from the 5' end of known KSHV ORFs. Similarly, primers were
chosen to amplify sequences from cellular genes and nonhuman/nonviral
sequences which were used as positive and negative hybridization
controls. The genes chosen were those encoding ubiquitin (M26880),
tyrosine 3-monooxygenase activation protein (NM_003404), pyrophosphate phosphoribosyltransferase (V00530), glyceraldehyde 3-phosphate dehydrogenase (X01677),
-tubulin (K00558), major histocompatibility complex (MHC) class I HLA-B (X75953),
-actin (X00351), highly basic
protein (X56932), ribosomal protein S9 (U14971), luciferase (E15166),
and tobacco mosaic virus 180-kDa protein (D78608). The primers used are
listed at www.biochem.ucl.ac.uk/bsm/virus_database/KSHVarray.html. Each
array element was cloned into either pBluescript (Stratagene) or pGEM-T
Easy (Promega), and the sequence was verified (Beckman). Common vector
primers were designed to amplify the cloned array elements. The PCR
products were purified using a Qiagen 96-well PCR purification system
and concentrated by ethanol precipitation. Finally, the DNA was
resuspended in water at 400 ng/µl, and approximately 36 ng of DNA was
spotted in duplicate on Hybond-N membrane (Amersham) using a
high-density gridder (Eurogentec). The DNA on the arrays was denatured
(in 0.66 M NaCl-0.5 M NaOH), neutralized (in 40 mM phosphate buffer,
pH 7.3), and then UV cross-linked to the membrane.
Quality control of DNA deposition.
The quality of array
element spotting was determined by the hybridization of
33P-labeled oligonucleotide probes specific for common
primer sequences present at the ends of the PCR products.
Oligonucleotide probes were end labeled with [
-33P]ATP
(ICN) using T4 polynucleotide kinase (Promega). Labeled probes were
separated from unincorporated label by ethanol precipitation with
lithium chloride. The arrays were preincubated for 30 min in ExpressHyb
hybridization solution (Clontech) with denatured salmon sperm DNA (100 µg/ml; Roche) at 42°C. The labeled oligonucleotides were hybridized
to the arrays for 18 h at 42°C in 5 ml of ExpressHyb with salmon
sperm DNA (100 µg/ml). The arrays were washed twice at 50°C in 2×
SSC (0.3 M NaCl plus 0.03 M sodium citrate)-0.1% sodium dodecyl
sulfate (SDS), with a final wash in 0.1× SSC-0.1% SDS. Bound probe
was detected using a phosphor screen (Molecular Dynamics), and the
signals were quantitated by phosphorimaging using ArrayVision software
(Imaging Research). For quantitation, the local background was
subtracted from each array element. Only complete, evenly spotted
arrays were used in the subsequent experiments. The oligonucleotides
were stripped from the arrays by the addition of boiling 0.5% SDS,
which was allowed to cool to 22°C with agitation. Stripping
efficiency was assessed by phosphorimaging. The Spearman rank order
correlation of probe bound to each array element for each array
compared to all others was found using the program Statistica (Statsoft).
Cell culture. The cell line BC-3 (2) was grown in RPMI 1640 medium (Gibco BRL) supplemented with 10% fetal calf serum, penicillin and streptomycin (100 U/µl), and ciprofloxacin (40 µg/ml). The culture was maintained between approximately 105 and 106 cells per ml. The herpesvirus-negative Burkitt's lymphoma cell line Ramos (24) was grown under the same conditions.
Induction of viral replication and RNA purification.
Before
induction of virus replication, dead cells were removed from the
cultures by density centrifugation through Lymphoprep (Nycomed). Cells
were then resuspended in fresh medium, and viral replication was
induced by the addition of TPA (Sigma) at 20 ng/µl. BC-3 cells were
harvested after 0, 2, 4, 10, 24, 34, 48, and 72 h, pelleted, and
washed once with phosphate-buffered saline. The cell pellet was frozen
immediately at
80°C or lysed in RLT lysis buffer (Qiagen) before
freezing. As a control, the same procedure was followed for BC-3 cells
but without the addition of TPA. RNA was purified using Qiagen's
RNeasy kit and quantitated by UV spectrophotometry. RNA quality was
assessed by denaturing agarose gel electrophoresis. The RNA was DNase I
treated (Promega) and repurified by phenol extraction and ethanol precipitation.
cDNA synthesis and array labeling.
Between 4 and 24 µg of
total RNA was used in each RT reaction. The cDNA synthesis was primed
using a pool of gene- and sense-strand-specific 3' primers (0.2 µmol). [
-33P]dATP-labeled cDNA was prepared using a
Strip-EZ RT kit (Ambion). cDNA was separated from unincorporated
nucleotides using Microspin SR-400 columns (Amersham). The labeled
probe was denatured by incubation in 0.1 M NaOH-0.1 mM EDTA at 68°C
and then neutralized with 1 M NaH2PO4. Human
Cot-1 DNA (Gibco BRL) was added to the probe to suppress
cross-hybridization to repetitive DNA. The prehybridization and
hybridization steps as described above except for a higher hybridization temperature of 64°C. Washes as described above were performed at 65°C. The signal was quantitated as before. Labeled cDNA
probe was stripped from the arrays using the Strip-EZ system (Ambion),
and the process was checked by phosphorimaging. Arrays were stored at
4°C on filter paper (Whatman) saturated with 0.1× SSC-0.1% SDS and
were rinsed in 0.1× SSC-0.1% SDS at 68°C before being used again.
Data processing and cluster analysis.
Local background for
each array element was subtracted, and the mean signal from the
duplicate spots was calculated. This gives one data point for each
viral gene and two for each cellular gene to assess hybridization
consistency. The complete data set can be viewed at
www.biochem.ucl.ac.uk/bsm/virus_database/KSHVarray.html. The mean
uninduced expression values were calculated for each viral gene across
all uninduced samples, and from this a median value was generated. This
value was then doubled and used as the divisor to transform the data
from absolute expression values to ratios. The data set was then
converted to log base 2, and before the induced samples were clustered,
genes were normalized across the experimental data set (the sum of the
squares set to 1) to equalize the magnitude of the expression
vectors (18). To control for differences in amounts of RNA
and the age of isotope in each experiment, the arrays were mean
centered using the expression of a subset of the cellular genes (those
encoding glyceraldehyde 3-phosphate dehydrogenase,
-tubulin, and
ribosomal protein S9) which were deemed nonchanging by their covariance
across all arrays. The covarying housekeeping genes were determined by
generating a Pearson correlation matrix for all the cellular genes
using Statistica (Statsoft). The mean centered data set was then
imported into the program Cluster (18), and the genes were
ordered using a self-organizing map algorithm (12) (the
number of nodes was set to
n). The genes and arrays were
clustered by average linkage hierarchical clustering using the
uncentered Pearson correlation as the similarity metric. To cluster the
arrays, each gene was weighted based on the local density of row
vectors in its vicinity. The results were visualized with the software
TreeView (18). All viral genes were clustered except for
ORFs 35, 50, 60, 68 and K15 exon 8 due to their cross-reaction with
Ramos cell RNA and ORF 33, whose expression could not be detected.
RT-PCR. RNA was prepared from BC-3 cells as for array analysis. cDNA was synthesized from 5 µg of total RNA primed with oligo(dT) primers (Stratagene), using SuperScript II (Gibco BRL) according to the manufacturer's instructions. Genomic DNA was purified from BC-3 cells using Qiagen's QIAamp DNA Mini kit. PCR was performed on 1/10 volume of cDNA using Taq polymerase (Roche) or the Expand Long Template PCR system (Roche). The primers used were as follows: for K9, ATGGACCCAGGCCAAAGACC and TTATTGCATGGCATCCCATAACG; for K10/10.1, ATGCCTAAAGCCGGTGGCTC and TCAATGTAGACTATCCCAAATGG; for K10.5/10.7, ATGGCGGGACGCAGGCTTAC and TTAGTCATCACATGTAACTGAACG; for K11/vIRF-2, ATGCCTCGCTACACGGAGTC and TTAGTCTCTGTGGTAAAATGGG; and for K10.1 splice (see Fig. 5D), GGACATTTGTCAAAGGAGCTA and CAAATGTGTCGCTGTACCGT. Splice sites were predicted and verified by software at the Berkeley Drosophila Genome Project (www.fruitfly.org/seq_tools/splice.html).
| |
RESULTS |
|---|
|
|
|---|
A DNA array for KSHV. To fully represent the coding potential of the KSHV genome on the array, we designed a set of PCR primers to amplify sequences from 88 known ORFs and some KSHV gene-specific exons. Cloned array elements were checked for the possibility of cross-hybridization both against each other and against host genes by searching GenBank using pairwise sequence analysis. No array elements were found to have significant homology to sequences other than those they represent. The arrays consist of a total of 288 separate elements spotted onto nylon membranes. Every KSHV PCR product was spotted in duplicate, and every cellular PCR product was spotted in quadruplicate. The cellular genes were split between different parts of the array to assess the consistency of hybridization.
The spotting of every element on each array was checked by hybridization of 33P-labeled oligonucleotides complementary to the common PCR primers. Quantitation of these signals showed the spotting to be very consistent. Within each array, the average variation in the amount of bound probe detected between duplicate spots was measured at ±5%. Patterns of spotting between arrays were also found to be almost identical; the Pearson correlation coefficient of bound probe to array elements between different arrays was 0.93 or above (data not shown). The arrays were used to examine virus gene expression during latency and lytic viral replication. Total RNA was extracted from BC-3 cells at different time points (0 to 72 h) with or without the addition of TPA, which induces lytic replication. To confirm the reproducibility of the arrays, we performed duplicate experiments representing 0, 24, 34, 48, and 72 h after induction. To control for the sensitivity of the arrays, luciferase RNA was added to the samples before labeling. This showed that RNA present at 1:100,000 (wt/wt), approximately equivalent to 10 copies per cell, could be detected at 10-fold above background. This sensitivity compares well with the known sensitivity of glass microarrays (40, 51). Tobacco mosaic virus elements acted as negative controls and on average gave a signal only 1.3-fold above background (standard deviation of 0.3). To further test the specificity of the arrays, we extracted RNA from Ramos cells, a KSHV-negative B-cell line, and hybridized it to an array. Almost all of the virus genes appeared negative, showing that the vast majority of the probes are specific for KSHV RNA. However, five elements, corresponding to ORFs 35, 50, 60, and 68 and K15 exon 8 exhibited cross-hybridization with Ramos cellular RNAs and therefore were not included in further analyses.Gene expression analysis by KSHV arrays.
Examples of results
from the arrays are shown in Fig. 1 and
represent genes expressed during latency and 24 h after the
induction of lytic replication with TPA. Both conditions are
represented by the results from two independent experiments. The signal
intensities are identical between the duplicate sets of cellular genes
on the individual arrays, suggesting consistent hybridization results. Gene expression values (means and standard errors from two samples) for
uninduced cells show that the genes fall into two main classes at these
time points (Fig. 1A). The signal from the majority of array elements
forms a baseline, while the expression of a few genes (those encoding
v-FLIP [ORF 71], v-cyclin [ORF 72], LNA-1 [ORF 73], K7, T1.1
[nut-1], T0.7, K10, and vOx-2 [K14]) is detected at
significantly higher levels. The small standard errors indicate that
duplicate samples give identical gene expression patterns. Even genes
expressed at low levels, such as the LNA-1 gene, are consistently and
significantly detected above the baseline, as shown by the absence of
significant error bars. Therefore, the arrays are accurate and highly
reproducible.
|
KSHV gene expression during latency.
Although KSHV is under
tight transcriptional control in uninduced BC-3 cells, lytic
replication can clearly be induced with TPA, leading to differential
KSHV gene expression (Fig. 1C). Lytic replication also occurs
spontaneously in around 1% of uninduced BC-3 cells (52).
To order and compare those genes that were being expressed in latent
and lytic cells, we assembled all data from both uninduced and induced
cells at all time points and clustered the viral genes using the
software Cluster (18). The hierarchical clustering
algorithm groups genes based on how their expression varies over all
samples. A dendrogram is generated with genes sharing similar patterns
of expression situated on the same branch. The branch lengths represent
the degree of similarity between the genes. The output of this
algorithm as applied to our data is shown in Fig.
2A. Shades of red signify detection of
expression at levels sufficiently above the baseline (as defined by the
median expression level [Materials and Methods]) to be judged
significant. All genes are colored green or black in Ramos cells, a
B-cell line negative for KSHV, as are most genes in all uninduced
samples, indicating that these genes are not detectable (not expressed) in these samples. The small number of genes expressed in every uninduced sample (red) correspond exactly to those shown to be above
the baseline signal (Fig. 1A). After hierarchical clustering, these
genes also form their own branch of the tree, corresponding to genes
for which expression can consistently be detected in uninduced cells.
The branch splits into two subbranches, one corresponding to v-FLIP,
v-cyclin, and LNA-1 (ORFs 71, 72, and 73, respectively) and the other
containing vOx-2 (K14), K7, nut-1, T0.7, and K10 (Fig. 2B). Previous
work has shown that transcripts encoding v-FLIP, v-cyclin, and LNA-1
are present during latent infection of PEL cell lines and show a slight
increase upon the induction of lytic replication (14, 45).
This branch thus represents latent (class I) transcripts. All three
genes are transcribed together from the same initiation site on two
overlapping transcripts (14, 39, 45). Their clustering
together due to their similar expression profiles therefore gives us
further confidence that the arrays are able to represent accurately
biological information.
|
KSHV gene expression during lytic replication: genes sharing
similar functions are coordinately expressed.
Most of the KSHV
genes are not detectable in latent BC-3 cells. However, their
expression increases over time after the induction of lytic replication
(Fig. 2A). Different genes reach significant levels of expression at
different time points, and cluster analysis arranges them into three
main groups. To determine whether the timing of gene expression
correlated with proposed gene function, we first ordered the data from
the TPA induction time course with a self-organizing map
(12) and then grouped the lytic genes by hierarchical
clustering (Fig. 3).
The order of the genes reflects the relative time when expression is
first detected, from earliest to latest. Hierarchical clustering
resulted in three main branches comprising genes with similar patterns
of expression; we have named these classes primary lytic genes,
secondary lytic genes, and tertiary lytic genes. The mean expression
pattern of genes in each of these classes was determined, illustrating
the time at which each group of genes was detected at levels greater
than double the uninduced median gene expression level (Fig.
4A). Although expression of the tertiary
lytic genes was not significantly above the uninduced median expression
level until after 48 h, their level of expression starts to
increase prior to this (Fig. 4A). Therefore, the relative times at
which gene expression is detected by any method is intrinsically linked
to the sensitivity of the detection system used. In addition, to
perform extensive cross-comparisons, all genes should be measured by
the same method at the same time.
|
|
Array analysis can predict the organization and function of viral
genes.
It has previously been noted that the coexpression of
uncharacterized genes with those of known function may provide a means of gaining clues to the functions of these genes (18). In
addition to containing clones of previously identified ORFs, the array also includes a number of elements that correspond to presumed noncoding intergenic regions (data not shown). Preliminary data suggest
that some of these may be transcribed. One such clone corresponds to a
sequence located between K10.5 and K11 (91091 to 91380 in U75698) in
block g (35). This region of the genome encodes two ORFs,
vIRF-1 (ORF K9) (5, 32, 35) and vIRF-2 (6),
which have both sequence and functional homology to cellular IRFs.
Block g also contains a further two putative ORFs which have homology
to IRFs (35), named K10.1 and K10.5 (GenBank accession no.
U93872, submitted by F. Neipel et al. [6]). The ORF that
we refer to as K10.5 has also been named K10.1 (32). K10, K10.1, K10.5, K11, and vIRF-2 proteins all share homology with vIRF-1
by pairwise sequence analysis. The vIRF-1, vIRF-2, K10.1, and K11 genes
are all classified as secondary lytic genes by cluster analysis (Fig.
4). The array element corresponding to the region between K10.5 and K11
is also clustered in this branch [labeled K10.7 (Putative ORF) in Fig.
3]. This information, along with its genomic location, suggested that
this clone might represent a novel ORF with homology to the known
vIRFs. ORF analysis showed that the array element formed part of a
novel ORF (named K10.7) that corresponds to nucleotides 91394 to 90936 in KSHV genomic sequence U75698. Multiple sequence alignment shows that
this ORF shares homology with vIRF-1, vIRF-2, K10.1, and two human IRFs
in part of the N-terminal DNA binding domain (6) (Fig. 5A).
|
| |
DISCUSSION |
|---|
|
|
|---|
We have described the creation of a nylon membrane-based array for the study of KSHV that has yielded highly consistent and reproducible results. We have analyzed KSHV gene expression during latency and lytic replication. The arrays are able to detect the small number of transcripts that were previously shown to be expressed during latency. The ordering of the array data by cluster analysis separates latent and lytic genes and generates a temporal program of lytic gene expression. The division of the lytic genes into three main classes (primary, secondary, and tertiary) gives a simple means of assessing when the expression of these genes becomes detectable.
Analysis of the relative levels of gene expression and predicted functions of the KSHV genes provides detailed insight into the biology of this herpesvirus. The array results confirm previous Northern blot analysis that the v-FLIP, v-cyclin, and LNA-1 genes are latent genes only marginally upregulated during lytic infection and that the T0.7 transcript is also present during latency (34, 36, 45). Cluster analysis and RT-PCR suggest that K10 may be a latent gene that is induced after the induction of lytic replication. Array data and RT-PCR show that K10 is alternatively spliced to give two forms, K10 and K10/10.1. Only K10/10.1, which is a lytic transcript, encodes a protein with a putative DNA binding domain. A protein of 100 kDa, closely matching the predicted size of K10/10.1, was previously found to be induced after TPA treatment of PEL cell lines (23). Further work is needed to confirm whether K10 protein is present in latent cells and whether the gene is alternatively spliced during lytic replication.
The expression patterns of the lytic genes also correlates well with previously published Northern blot analyses. The primary lytic genes encoding vIL-6, K12, K5, nut-1, K8, and K4 have previously been shown to be expressed between 8 and 13 h after induction (44). ORF65 (25, 44) and ORF17 (47), which encode the small viral capsid antigen and the KSHV protease/assembly protein, respectively, are expressed late during lytic replication and are both classified as secondary lytic genes on the array. Similarly, most of the secondary lytic genes and all of the tertiary lytic genes have been classified as class III transcripts (37).
The expression of most of the KSHV genes has not been analyzed before. The functions of only a few genes have been shown experimentally, but putative functions have been assigned to most of the genes based on their homology to previously characterized herpesviruses (35). Our analysis shows that the relative time at which the expression of different genes is detected correlates well with the stage of the virus life cycle in which that gene is thought to act. For example, genes which encode proteins thought to be involved in virus gene regulation are all expressed early and precede those that form the virus particle or which are involved in its assembly (Fig. 3 and 4B). The one exception to this is ORF 67, which is already detectable by 4 h postinduction. This gene is thought to encode a tegument protein due to its homology to the Epstein-Barr virus gene BFRF1 (35), which is also expressed early in lytic replication (19). The expression of ORF 67 as a primary lytic gene suggests functions consistent with those of the other genes expressed at this time, namely, cell regulation, signal transduction, and virus gene regulation.
Analysis of functional annotation in the context of gene expression also shows differences in temporal expression of certain functional classes. Genes encoding products involved in DNA replication such as DNA polymerase (ORF 9), PF-8 processivity factor (ORF 59), single-stranded DNA binding protein (ORF 6), and the viral primase (ORF 56) are detected early and show similar patterns of expression (Fig. 3, pink text). ORFs 40, 41, and 44 are also thought to be involved in DNA replication but are not detected until later during the life cycle (Fig. 3, pink text). It is possible that these proteins are not required for DNA replication from latent episomes but are packaged by the virus and act to replicate viral DNA after infection. Similarly, genes involved in DNA repair and nucleotide metabolism are also split into two groups (Fig. 3, blue text); ORFs 2, 46, 61, and 70 are expressed quite early with genes such as the primase and processivity factor genes, while ORFs 21, 36, 37, and 54 are expressed later with structural genes. Therefore, the requirement for genes with functions in this class may be split between initial DNA replication and subsequent DNA maturation and packaging. Such data are consistent with the alkaline exonuclease of herpes simplex virus type 1, which is dispensable for DNA replication but required for DNA maturation (28).
Viral homologs of cellular regulatory or signal transduction proteins are primary or secondary lytic genes (Fig. 3, orange text). Of these, the secondary lytic genes (encoding vMIP-III, vIRFs, and complement binding protein) are all thought to interact with the host immune system. Of particular interest is the relationship between expression of the three macrophage inflammatory protein homologs vMIP-I, -II, and -III. vMIP-I and -II are closely related and are thought to have evolved by gene duplication within the virus genome (4). vMIP-III is more distantly related and probably derived independently from another member of the CC chemokine family (32, 35). vMIP-I and -II are both primary lytic genes, whereas vMIP-III is in the secondary lytic gene cluster. Thus, the array data suggest that these genes are also differentially regulated at the level of transcription and may have distinct functions in the virus life cycle.
The expression profiles of the many uncharacterized KSHV genes provide clues to their function by virtue of their association with previously characterized genes. The discovery of a novel ORF, K10.7, by this approach coupled with other techniques shows that KSHV encodes four full-length IRF-related proteins. K10.5/10.7 has also recently been identified as a novel lytic gene in another study, where it was named vIRF-3 (27). Therefore, this kind of analysis should lead to further insights into KSHV gene function.
Many elements from adjacent genes on the genome also appear to be
clustered near one another on the array. This may represent overlapping
transcriptional units where one ORF forms the 3' untranslated region of
the transcript from another upstream ORF. An example of such an event
is the extension of K15 transcripts through K14.1 and ORF75
(22). The arrays are unable to completely discriminate against presumably noncoding transcripts such as these. We have tried
to minimize their detection by priming cDNA synthesis with sense-strand-specific primers. However, this does not completely prevent the K14.1 probe from detecting K15 transcripts primed by the
ORF75 primer. The correlation between genomic location and expression
could also be due to probes detecting spliced or polycistronic
transcripts or due to coregulation of genes by common or related
promoters. An example of a polycistronic transcript whose component
genes cluster in terms of expression are the latent v-FLIP, v-cyclin,
and LNA-1 genes. Examples of spliced ORFs sharing expression profiles
are the different exons of K15, ORFs 29a and 29b, and, as shown here,
K11 and vIRF-2. Figure 6 shows the
locations of genes belonging to each expression class. The map
indicates other areas of the KSHV genome where more detailed transcript mapping would help discriminate between noncoding transcriptional read-through events, polycistronic transcripts, splicing, and shared
promoters.
|
There are some discrepancies between our results and those of others. We were unable to confirm detection of K15 expression in latent cells (11, 22), possibly because of differences in the cell lines used. However, both studies detected different banding patterns on Northern blots depending on the K15 probe used, which may be due to cross-hybridization with an unknown RNA (11). This explanation is consistent with the array results showing cross-hybridization of K15 exon 8 with RNA from Ramos cells, which occurred despite the use of stringent hybridization conditions (64°C). A decrease in the abundance of early gene transcripts 48 h after induction has also been reported (44). However, our results indicate that these transcripts remain constant or continue to accumulate during lytic replication. RNA loading controls suggest that the apparent decrease in the expression of KSHV genes may be due to a progressive reduction in the total amount of RNA present after induction (44). Consistent with this, we found that late time points after induction showed a decrease in the amount of total RNA extracted from equal amounts of cells and an additional decrease in the absolute amount of all cellular mRNAs hybridizing to the arrays. This is most likely due to the proapoptotic effect of TPA (53) and virus-induced shutdown of cellular genes (38). To maintain similar levels of hybridization on the arrays, we used greater amounts of total RNA in the cDNA synthesis reaction and discarded data from any array where the housekeeping gene signal was more than threefold different from the mean level.
The KSHV array provides a rapid, accurate, and reproducible method to analyze the global gene expression that constitutes the virus transcriptome. Such arrays provide a means of determining the KSHV transcriptome in the three tumor types that result from KSHV infection. The combination of viral and cellular genes in a single array will also lead to a greater understanding of the host-pathogen interactions that occur during KSHV infection. The use of post-genomic research methods and detailed bioinformatics analysis of such results will expand our understanding of virus-induced diseases.
| |
ACKNOWLEDGMENTS |
|---|
We gratefully acknowledge the support and advice of Robin Weiss. We also acknowledge Pieter Goedhart and Driss Talibi at Eurogentec for gridding of the KSHV array.
This work was funded by the Medical Research Council (MRC) (R.G.J. and P.K.), the Biotechnology and Biological Sciences Research Council (BBSRC) (M.M.A.), and the Cancer Research Campaign (CRC) (C.B.). R.G.J. is enrolled in the Graduate Program of the MRC Laboratory for Molecular Cell Biology.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Wohl Virion Centre, Windeyer Institute, University College London, 46 Cleveland St., London W1T 4JF , United Kingdom. Phone: 44 20 7679 9559. Fax: 44 20 7679 9555. E-mail: p.kellam{at}ucl.ac.uk.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alizadeh, A. A., M. B. Eisen, R. E. Davis, C. Ma, I. S. Lossos, A. Rosenwald, J. C. Boldrick, H. Sabet, T. Tran, X. Yu, J. I. Powell, L. Yang, G. E. Marti, T. Moore, J. Hudson, Jr., L. Lu, D. B. Lewis, R. Tibshirani, G. Sherlock, W. C. Chan, T. C. Greiner, D. D. Weisenburger, J. O. Armitage, R. Warnke, L. M. Staudt, et al. 2000. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511[CrossRef][Medline]. |
| 2. |
Arvanitakis, L.,
E. A. Mesri,
R. G. Nador,
J. W. Said,
A. S. Asch,
D. M. Knowles, and E. Cesarman.
1996.
Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus.
Blood
88:2648-2654 |
| 3. |
Ballestas, M. E.,
P. A. Chatis, and K. M. Kaye.
1999.
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
Science.
284:641-644 |
| 4. |
Boshoff, C.,
Y. Endo,
P. D. Collins,
Y. Takeuchi,
J. D. Reeves,
V. L. Schweickart,
M. A. Siani,
T. Sasaki,
T. J. Williams,
P. W. Gray,
P. S. Moore,
Y. Chang, and R. A. Weiss.
1997.
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines.
Science
278:290-294 |
| 5. |
Burysek, L.,
W. S. Yeow,
B. Lubyova,
M. Kellum,
S. L. Schafer,
Y. Q. Huang, and P. M. Pitha.
1999.
Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300.
J. Virol.
73:7334-7342 |
| 6. | Burysek, L., W. S. Yeow, and P. M. Pitha. 1999. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). J. Hum. Virol. 2:19-32[Medline]. |
| 7. |
Cesarman, E.,
Y. Chang,
P. S. Moore,
J. W. Said, and D. M. Knowles.
1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.
N. Engl. J. Med.
332:1186-1191 |
| 8. |
Cesarman, E.,
P. S. Moore,
P. H. Rao,
G. Inghirami,
D. M. Knowles, and Y. Chang.
1995.
In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.
Blood
86:2708-2714 |
| 9. |
Chambers, J.,
A. Angulo,
D. Amaratunga,
H. Guo,
Y. Jiang,
J. S. Wan,
A. Bittner,
K. Frueh,
M. R. Jackson,
P. A. Peterson,
M. G. Erlander, and P. Ghazal.
1999.
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression.
J. Virol.
73:5757-5766 |
| 10. |
Chang, Y.,
E. Cesarman,
M. S. Pessin,
F. Lee,
J. Culpepper,
D. M. Knowles, and P. S. Moore.
1994.
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science
266:1865-1869 |
| 11. |
Choi, J. K.,
B. S. Lee,
S. N. Shim,
M. Li, and J. U. Jung.
2000.
Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome.
J. Virol.
74:436-446 |
| 12. |
Chu, S.,
J. DeRisi,
M. Eisen,
J. Mulholland,
D. Botstein,
P. O. Brown, and I. Herskowitz.
1998.
The transcriptional program of sporulation in budding yeast.
Science
282:699-705 |
| 13. |
Decker, L. L.,
P. Shankar,
G. Khan,
R. B. Freeman,
B. J. Dezube,
J. Lieberman, and D. A. Thorley-Lawson.
1996.
The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients.
J. Exp. Med.
184:283-288 |
| 14. |
Dittmer, D.,
M. Lagunoff,
R. Renne,
K. Staskus,
A. Haase, and D. Ganem.
1998.
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.
J. Virol.
72:8309-8315 |
| 15. |
Djerbi, M.,
V. Screpanti,
A. I. Catrina,
B. Bogen,
P. Biberfeld, and A. Grandien.
1999.
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
J. Exp. Med.
190:1025-1032 |
| 16. |
Dupin, N.,
T. L. Diss,
P. Kellam,
M. Tulliez,
M. Q. Du,
D. Sicard,
R. A. Weiss,
P. G. Isaacson, and C. Boshoff.
2000.
HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma.
Blood
95:1406-1412 |
| 17. |
Dupin, N.,
C. Fisher,
P. Kellam,
S. Ariad,
M. Tulliez,
N. Franck,
E. van Marck,
D. Salmon,
I. Gorin,
J. P. Escande,
R. A. Weiss,
K. Alitalo, and C. Boshoff.
1999.
Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.
Proc. Natl. Acad. Sci. USA
96:4546-4551 |
| 18. |
Eisen, M. B.,
P. T. Spellman,
P. O. Brown, and D. Botstein.
1998.
Cluster analysis and display of genome-wide expression patterns.
Proc. Natl. Acad. Sci. USA
95:14863-14868 |
| 19. |
Farina, A.,
R. Santarelli,
R. Gonnella,
R. Bei,
R. Muraro,
G. Cardinali,
S. Uccini,
G. Ragona,
L. Frati,
A. Faggioni, and A. Angeloni.
2000.
The BFRF1 gene of Epstein-Barr virus encodes a novel protein.
J. Virol.
74:3235-3244 |
| 20. | Friborg, J., Jr., W. Kong, M. O. Hottiger, and G. J. Nabel. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889-894[Medline]. |
| 21. | Geiss, G. K., R. E. Bumgarner, M. C. An, M. B. Agy, A. B. van 't Wout, E. Hammersmark, V. S. Carter, D. Upchurch, J. I. Mullins, and M. G. Katze. 2000. Large-scale monitoring of host cell gene expression during HIV-1 infection using cDNA microarrays. Virology 266:8-16[CrossRef][Medline]. |
| 22. |
Glenn, M.,
L. Rainbow,
F. Aurad,
A. Davison, and T. F. Schulz.
1999.
Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus.
J. Virol.
73:6953-6963 |
| 23. | Katano, H., Y. Sato, T. Kurata, S. Mori, and T. Sata. 2000. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335-344[CrossRef][Medline]. |
| 24. | Klein, G., B. Giovanella, A. Westman, J. S. Stehlin, and D. Mumford. 1975. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Intervirology 5:319-334[Medline]. |
| 25. | Lin, S. F., R. Sun, L. Heston, L. Gradoville, D. Shedd, K. Haglund, M. Rigsby, and G. Miller. 1997. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen. J. Virol. 71:3069-3076[Abstract]. |
| 26. | Lockhart, D. J., and E. A. Winzeler. 2000. Genomics, gene expression and DNA arrays. Nature 405:827-836[CrossRef][Medline]. |
| 27. |
Lubyova, B., and P. M. Pitha.
2000.
Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors.
J. Virol.
74:8194-8201 |
| 28. | Martinez, R., R. T. Sarisky, P. C. Weber, and S. K. Weller. 1996. Herpes simplex virus type 1 alkaline nuclease is required for efficient processing of viral DNA replication intermediates. J. Virol. 70:2075-2085[Abstract]. |
| 29. | Miller, G., L. Heston, E. Grogan, L. Gradoville, M. Rigsby, R. Sun, D. Shedd, V. M. Kushnaryov, S. Grossberg, and Y. Chang. 1997. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J. Virol. 71:314-324[Abstract]. |
| 30. |
Moore, P. S.,
C. Boshoff,
R. A. Weiss, and Y. Chang.
1996.
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV.
Science
274:1739-1744 |
| 31. | Moore, P. S., and Y. Chang. 1998. Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV. Trends Genet. 14:144-150[CrossRef][Medline]. |
| 32. | Neipel, F., J. C. Albrecht, and B. Fleckenstein. 1997. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71:4187-4192[Medline]. |
| 33. | Radkov, S. A., P. Kellam, and C. Boshoff. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and together with the oncogene hras transforming primary rat cells. Nat. Med. 6:1121-1127[CrossRef][Medline]. |
| 34. | Renne, R., W. Zhong, B. Herndier, M. McGrath, N. Abbey, D. Kedes, and D. Ganem. 1996. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:342-346[CrossRef][Medline]. |
| 35. |
Russo, J. J.,
R. A. Bohenzky,
M. C. Chien,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
Y. Chang, and P. S. Moore.
1996.
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867 |
| 36. |
Sadler, R.,
L. Wu,
B. Forghani,
R. Renne,
W. Zhong,
B. Herndier, and D. Ganem.
1999.
A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus.
J. Virol.
73:5722-5730 |
| 37. |
Sarid, R.,
O. Flore,
R. A. Bohenzky,
Y. Chang, and P. S. Moore.
1998.
Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1).
J. Virol.
72:1005-1012 |
| 38. | Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and Y. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nat. Med. 3:293-298[CrossRef][Medline]. |
| 39. |
Sarid, R.,
J. S. Wiezorek,
P. S. Moore, and Y. Chang.
1999.
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.
J. Virol.
73:1438-1446 |
| 40. |
Schena, M.,
D. Shalon,
R. Heller,
A. Chai,
P. O. Brown, and R. W. Davis.
1996.
Parallel human genome analysis: microarray-based expression monitoring of 1000 genes.
Proc. Natl. Acad. Sci. USA
93:10614-10619 |
| 41. | Sharp, T. V., and C. Boshoff. 2000. Kaposi's sarcoma-associated herpesvirus: from cell biology to pathogenesis. IUBMB Life 49:97-104[Medline]. |
| 42. |
Soulier, J.,
L. Grollet,
E. Oksenhendler,
P. Cacoub,
D. Cazals-Hatem,
P. Babinet,
M. F. d'Agay,
J. P. Clauvel,
M. Raphael,
L. Degos, et al.
1995.
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.
Blood
86:1276-1280 |
| 43. | Staskus, K. A., W. Zhong, K. Gebhard, B. Herndier, H. Wang, R. Renne, J. Beneke, J. Pudney, D. J. Anderson, D. Ganem, and A. T. Haase. 1997. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:715-719[Abstract]. |
| 44. |
Sun, R.,
S. F. Lin,
K. Staskus,
L. Gradoville,
E. Grogan,
A. Haase, and G. Miller.
1999.
Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression.
J. Virol.
73:2232-2242 |
| 45. | Talbot, S. J., R. A. Weiss, P. Kellam, and C. Boshoff. 1999. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84-94[CrossRef][Medline]. |
| 46. |
Thompson, J. D.,
D. G. Higgins, and T. J. Gibson.
1994.
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
Nucleic Acids Res.
22:4673-4680 |
| 47. | Unal, A., T. R. Pray, M. Lagunoff, M. W. Pennington, D. Ganem, and C. S. Craik. 1997. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 71:7030-7038[Abstract]. |
| 48. | Zhong, W., and D. Ganem. 1997. Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J. Virol. 71:1207-1212[Abstract]. |
| 49. |
Zhong, W.,
H. Wang,
B. Herndier, and D. Ganem.
1996.
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.
Proc. Natl. Acad. Sci. USA
93:6641-6646 |
| 50. |
Zhu, F. X.,
T. Cusano, and Y. Yuan.
1999.
Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus.
J. Virol.
73:5556-5567 |
| 51. |
Zhu, H.,
J. P. Cong,
G. Mamtora,
T. Gingeras, and T. Shenk.
1998.
Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays.
Proc. Natl. Acad. Sci. USA
95:14470-14475 |
| 52. |
Zoeteweij, J. P.,
S. T. Eyes,
J. M. Orenstein,
T. Kawamura,
L. Wu,
B. Chandran,
B. Forghani, and A. Blauvelt.
1999.
Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
J. Virol.
73:5894-5902 |
This article has been cited by other articles: